Six-month follow-up of gut microbiota richness in patients with COVID-19

Yanfei Chen,Silan Gu,Yunbo Chen,Haifeng Lu,Ding Shi,Jing Guo,Wen-Rui Wu,Ya Yang,Yongtao Li,Kai-Jin Xu,Cheng Ding,Rui Luo,Chenjie Huang,Ling Yu,Min Xu,Ping Yi,Jun Liu,Jing-jing Tao,Hua Zhang,Longxian Lv,Baohong Wang,Jifang Sheng,Lanjuan Li
DOI: https://doi.org/10.1136/gutjnl-2021-324090
IF: 24.5
2021-04-08
Gut
Abstract:We read with great interest the recent article published in Gut in which Yeoh et al demonstrated that gut microbiota composition of recovered patients with COVID-19 remained significantly distinct from uninfected controls.1 Persisting symptoms, also known as 'long COVID-19', have been reported in a significant proportion of patients following hospital discharge.2 3 Gut dysbiosis might link to long COVID-19 risks.1 Few studies have focused on the recovery process of gut microbiota following SARS-CoV-2 infection. Here, we conducted a prospective study to longitudinally monitor alterations of gut microbiota in patients with COVID-19 using 16S rDNA sequencing (detailed methods in ). Faecal microbiota was monitored at three timepoints, acute phase (from illness onset to viral clearance), convalescence (from viral clearance to 2 weeks after hospital discharge), postconvalescence (6 months after hospital discharge). The gut microbiota richness, measured by Chao 1 index, was obviously...
gastroenterology & hepatology
What problem does this paper attempt to address?